CASTLIGHT HEALTH, INC. Balance Sheet

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated balance sheets

In millions of USD, except per-share amounts

	Q3 FY2021 As of Sep 30, 2021	Q2 FY2021 As of Jun 30, 2021	Q1 FY2021 As of Mar 31, 2021	Q4 FY2020 As of Dec 31, 2020	Q3 FY2020 As of Sep 30, 2020	Q2 FY2020 As of Jun 30, 2020	Q1 FY2020 As of Mar 31, 2020	Q4 FY2019 As of Dec 31, 2019	Q3 FY2019 As of Sep 30, 2019	Q2 FY2019 As of Jun 30, 2019	Q1 FY2019 As of Mar 31, 2019	Q4 FY2018 As of Dec 31, 2018	Q3 FY2018 As of Sep 30, 2018	Q2 FY2018 As of Jun 30, 2018	Q1 FY2018 As of Mar 31, 2018	Q4 FY2017 As of Dec 31, 2017	Q3 FY2017 As of Sep 30, 2017	Q2 FY2017 As of Jun 30, 2017	Q1 FY2017 As of Mar 31, 2017	Q4 FY2016 As of Dec 31, 2016
Assets
Current assets:
Cash and cash equivalents
Deferred commissions and professional services costs
Marketable securities
Accounts receivable and other, net
Prepaid expenses and other current assets
Total current assets

Property and equipment, net
Marketable securities, noncurrent
Restricted cash, non-current
Deferred commissions
Accounting Standards Update 2014-09
Total deferred commissions

Deferred professional service costs
Accounting Standards Update 2014-09
Total deferred professional service costs

Intangible assets, net
Deferred commissions and professional services costs
Goodwill
Operating lease right-of-use assets, net
Other assets
Total assets

Liabilities and stockholders’ equity
Current liabilities:
Accounts payable
Accrued expenses and other current liabilities
Accrued compensation
Deferred revenue
Accounting Standards Update 2014-09
Total deferred revenue

Operating lease liabilities
Total current liabilities
Deferred revenue, non-current
Accounting Standards Update 2014-09
Total deferred revenue, non-current

Debt, non-current
Operating lease liabilities, non-current
Other liabilities, non-current
Total liabilities
Convertible preferred stock, $0.0001 par value; no and 64,475,662 shares authorized as of December 31, 2014 and 2013; no and 64,475,633 shares issued and outstanding as of December 31, 2014 and 2013
Stockholders’ equity:
Preferred stock, $0.0001 par value; 10,000,000 shares authorized as of December 31, 2020 and 2019; no shares issued and outstanding as of December 31, 2020 and 2019
Common stock
Class A
Class B common stock
Total common stock
Additional paid-in capital
Accumulated other comprehensive income
Accumulated deficit
Accounting Standards Update 2014-09
Total accumulated deficit

Total stockholders’ equity
Total liabilities and stockholders’ equity

Comments